AI-generated summary
The authors report a pilot study of 17 women with striae distensae, treated six times weekly with a TriPollar radiofrequency device. At one week after the final session, 38.2% of participants were rated to have 25-50% improvement and 11.8% 51-75% improvement, with no adverse effects reported. The authors describe the device as a promising alternative, though the small pilot design is a limit.
- Participants
- 17
- Who or what was studied
- Seventeen females with striae distensae and skin phototypes IV-V
- Limits stated in the abstract
- The abstract describes a pilot study with a small sample of 17 women and does not mention a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Pilot study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.